Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision tag Revision: v3.6.6 has been added to the page, replacing the previous Revision: v3.6.5, indicating the current version of the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.6.5 is now displayed on the page, replacing the previous Revision: v3.6.4. This appears to be a minor site version update and does not modify study details or visible content.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 reflects a deployment-level update; the change is limited to metadata and does not alter study details or displayed content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study title and related eligibility text now include angiosarcoma, and the contact person has been updated; the enrollment target and Lifileucel/TIL treatment details have been revised to reflect the new protocol and sites.SummaryDifference2%

- Check69 days agoChange DetectedFooter status shows a new Revision tag (v3.6.3) replacing the previous v3.6.2, representing a minor update to the page version.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a software update to the interface.SummaryDifference0.1%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.